Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy At-risk Adults
This study has been completed.
Study NCT00560313 Information provided by Novartis
First Received: November 16, 2007 Last Updated: November 16, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Meningococcal Disease
Additional conditions recognized in this trial
Meningococcal Infections
More general conditions related to this trial
Bacterial Infections
Gram-Negative Bacterial Infections
Neisseriaceae Infections
Interventions listed in this trial
Serogroup B meningococcal Vaccine
Sponsors listed in this trial
Novartis
Novartis Vaccines
Back to top of Main Content